C07C 279/08
Being further substituted by singly-bound oxygen atoms
Official title: being further substituted by singly-bound oxygen atoms
C07C279/08 (Being further substituted by singly-bound oxygen atoms) appears on 117 US grants and 118 published applications in this corpus.
Search patents in C07C- Granted patents
- 117
- Published applications
- 118
- Assignees
- 70
- Inventors
- 324
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 6 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 1 | 1 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 3 |
| 2009 | 4 | 2 |
| 2010 | 1 | 4 |
| 2011 | 4 | 7 |
| 2012 | 2 | 12 |
| 2013 | 2 | 6 |
| 2014 | 9 | 9 |
| 2015 | 7 | 13 |
| 2016 | 11 | 9 |
| 2017 | 7 | 10 |
| 2018 | 10 | 10 |
| 2019 | 4 | 4 |
| 2020 | 3 | 4 |
| 2021 | 2 | 5 |
| 2022 | 4 | 6 |
| 2023 | 2 | 2 |
| 2024 | 8 | 1 |
| 2025 | 4 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same30 Sep 2025US 12,427,346 B2Autotac Inc.
- Ligands for imaging cardiac innervation10 Jun 2025US 12,324,845 B2Lantheus Medical Imaging, Inc.
- Compound targeting norepinephrine transporter29 Apr 2025US 12,285,501 B2
- PPARδ activator8 Apr 2025US 12,268,672 B2Japan Science and Technology Agency
- AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same29 Oct 2024US 12,129,218 B2Autotac Inc.
- Compositions, methods, and systems for the synthesis and use of imaging agents29 May 2025US 2025/0170282 A1Lantheus Medical Imaging, Inc.
- Ligands for imaging cardiac innervation22 May 2025US 2025/0161500 A1Lantheus Medical Imaging, Inc.
- Prodrugs of Fumarates and Their Use in Treating Various Diseases24 Apr 2025US 2025/0127747 A1Alkermes Pharma Ireland Limited
- Prodrugs of Fumarates and Their Use in Treating Various Diseases25 Jan 2024US 2024/0024275 A1Alkermes Pharma Ireland Limited
- Bakuchiol derivatives, pharmaceutically acceptable salts thereof, and preparation method and use of the same7 Dec 2023US 2023/0391717 A1Jiangxi Shimei Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Aryl urea and related compounds65US 5,547,966 ABristol-Myers Squibb Company · 1996
- Benzamide derivatives and their use as vasopressin antagonists49US 6,054,457 AFujisawa Pharmaceutical Co., Ltd. · 2000
- Alkoxy compounds for disease treatment48US 7,982,071 B2Acucela Inc. · 2011
- Amide compounds and use of the same40US 6,174,887 B1Japan Tobacco Inc. · 2001
- Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them39US 5,352,667 A1994